Annovis Bio

Annovis Bio Makes Strides in Neurodegenerative Disease Treatment: 2023 Q4 Results Below Projections, Progress Seen in Clinical Trials

MALVERN, PA — In a recent financial report for 2023, Annovis Bio, Inc. (NYSE: ANVS) proclaimed progress in the battle against neurodegenerative diseases; however, the path to potential breakthroughs has …

Annovis Bio Makes Strides in Neurodegenerative Disease Treatment: 2023 Q4 Results Below Projections, Progress Seen in Clinical Trials Read More



Vishay Intertechnology

Vishay Intertechnology’s Specialty Thin Film Division Achieves Key Automotive Quality Certification

MALVERN, PA — Vishay Intertechnology, Inc. (NYSE: VSH), a global leader in the manufacture of electronic components, has announced a significant milestone for its Specialty Thin Film (STF) division. The company’s …

Vishay Intertechnology’s Specialty Thin Film Division Achieves Key Automotive Quality Certification Read More